Plasma ACE2 species are differentially altered in COVID‐19 patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma ACE2 species are differentially altered in COVID‐19 patients
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 35, Issue 8, Pages -
Publisher
Wiley
Online
2021-07-01
DOI
10.1096/fj.202100051r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19
- (2021) Maria A Pedrosa et al. CLINICAL SCIENCE
- Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
- (2021) Sheila K. Patel et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice
- (2021) Juan García-Arriaza et al. JOURNAL OF VIROLOGY
- A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection
- (2021) Cornelia Blume et al. NATURE GENETICS
- Angiotensin-Converting Enzyme 2 (ACE2) Elevation in Severe COVID-19
- (2021) Roman Reindl-Schwaighofer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19
- (2021) Alexander Kutz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
- (2020) Iziah E Sama et al. EUROPEAN HEART JOURNAL
- Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
- (2020) Sandro La Vignera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
- (2020) Andrew M. South et al. Nature Reviews Nephrology
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
- (2020) Meng-Yuan Li et al. Infectious Diseases of Poverty
- Sex difference and smoking predisposition in patients with COVID-19
- (2020) Hua Cai Lancet Respiratory Medicine
- Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans
- (2020) B. Robson COMPUTERS IN BIOLOGY AND MEDICINE
- The protein expression profile of ACE2 in human tissues
- (2020) Feria Hikmet et al. Molecular Systems Biology
- A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
- (2020) Michael R Garvin et al. eLife
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- Serum ACE-2, angiotensin II, and aldosterone levels are unchanged in patients with COVID-19
- (2020) Marina Rieder et al. AMERICAN JOURNAL OF HYPERTENSION
- Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation
- (2020) Lars Wallentin et al. EUROPEAN HEART JOURNAL
- Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
- (2020) Sukrit Narula et al. LANCET
- Sex differences in circulating proteins in heart failure with preserved ejection fraction
- (2020) Susan Stienen et al. Biology of Sex Differences
- Identifying Pathways and Networks Associated With the SARS-CoV-2 Cell Receptor ACE2 Based on Gene Expression Profiles in Normal and SARS-CoV-2-Infected Human Tissues
- (2020) Qiushi Feng et al. Frontiers in Molecular Biosciences
- Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement
- (2018) Dan Dou et al. Frontiers in Immunology
- Sex differences in the aging pattern of renin–angiotensin system serum peptidases
- (2017) A. Fernández-Atucha et al. Biology of Sex Differences
- Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease
- (2016) Hongpeng Jia SHOCK
- Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
- (2016) Hongjing Gu et al. Scientific Reports
- Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
- (2015) Inmaculada Lopez-Font et al. Frontiers in Neurology
- Characterization of Angiotensin-Converting Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular Cells
- (2014) Fengxia Xiao et al. PLoS One
- Downregulation of angiotensin-converting enzyme 2 by the neuraminidase protein of influenza A (H1N1) virus
- (2014) Xin Liu et al. VIRUS RESEARCH
- Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections
- (2014) Zhen Zou et al. Nature Communications
- Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
- (2014) Penghui Yang et al. Scientific Reports
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
- (2013) A. Heurich et al. JOURNAL OF VIROLOGY
- Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion
- (2013) Harshita Chodavarapu et al. PLoS One
- Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
- (2012) Nicola E. Clarke et al. PLoS One
- Increased Urinary Angiotensin-Converting Enzyme 2 in Renal Transplant Patients with Diabetes
- (2012) Fengxia Xiao et al. PLoS One
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
- (2010) A. Shulla et al. JOURNAL OF VIROLOGY
- Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
- (2010) Keiji Kuba et al. PHARMACOLOGY & THERAPEUTICS
- Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent
- (2010) Jun Liu et al. Biology of Sex Differences
- Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
- (2009) Hong Peng Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
- (2009) Shiori Haga et al. ANTIVIRAL RESEARCH
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63
- (2009) I. Glowacka et al. JOURNAL OF VIROLOGY
- 2009 H1N1 Influenza
- (2009) Seth J. Sullivan et al. MAYO CLINIC PROCEEDINGS
- Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
- (2008) Rebecca A. Lew et al. EXPERIMENTAL PHYSIOLOGY
- Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2
- (2008) Shunxin Wang et al. VIRUS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started